Shiro Kamakura
About
In The Last Decade
Shiro Kamakura
236 papers receiving 6.9k citations
Peers
Comparison fields: 5 of 126
- Cardiology and Cardiovascular Medicine 6.0k
- Molecular Biology 3.2k
- Pharmacology 423
- Oncology 401
- Surgery 334
Countries citing papers authored by Shiro Kamakura
This map shows the geographic impact of Shiro Kamakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Kamakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Kamakura more than expected).
Fields of papers citing papers by Shiro Kamakura
This network shows the impact of papers produced by Shiro Kamakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Kamakura. The network helps show where Shiro Kamakura may publish in the future.
Co-authorship network of co-authors of Shiro Kamakura
This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Kamakura. A scholar is included among the top collaborators of Shiro Kamakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Kamakura. Shiro Kamakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | Clinical Characteristics and Prognosis of Patients with Non-Type 1 Brugada-Pattern Electrocardiogram and a History of Ventricular Fibrillation | 3 |
| 3 | 7 | |
| 4 | 2 | |
| 5 | Abstract 13451: Prolonged PR Interval is Significantly Associated with Increased Risk of Cardiovascular Diseases and Strokes in a Population-based Cohort Study | 3 |
| 6 | 66 | |
| 7 | 1 | |
| 8 | 13 | |
| 9 | 160 | |
| 10 | 294 | |
| 11 | Mechanism and New Findings in Brugada Syndrome(Mechanisms and Future Challenge) | 1 |
| 12 | 16 | |
| 13 | The clinical impact of nonsustained ventricular tachycardia to the risk for sudden cardiac death in patients with non-ischemic dilated cardiomyopathy | 0 |
| 14 | Efficacy of nifekalant hydrochloride for the prevention of ventricular tachyarrhythmia : the QT interval should be prolonged but not so much | 8 |
| 15 | PJ-214 Efficacy of Nifekalant Hydrochloride for the Prevention of Ventricular Tachyarrhythmia : The QT Interval Should be Prolonged but not So Much(Arrhythmia, Pharmacological Therapy 3 (A) : PJ36)(Poster Session (Japanese)) | 0 |
| 16 | 9 | |
| 17 | 24 | |
| 18 | 14 | |
| 19 | -P34- THE ROLE OF VENTRICULAR ACTIVATION TIME (VAT) IN DETECTING VENTRICULAR DYSFUNCTION IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK : ECG, Mapping : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY | 0 |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.